Search

Displaying results 7941 - 7950 of 10000 in total
  1. Drug

    Trifezolac

    go.drugbank.com/drugs/DB21380
    Experimental

    Trifezolac is a small molecule drug. The usage of the INN stem '-ac' in the name indicates that Trifezolac is a anti-inflammatory agent, ibufenac derivative.

  2. Drug

    Pulrodemstat

    go.drugbank.com/drugs/DB21497
    Experimental

    Pulrodemstat is a small molecule drug. The usage of the INN stem '-demstat' in the name indicates that Pulrodemstat is a Lysine-specific histone demethylase inhibitor.

  3. Drug

    Zavolosotine

    go.drugbank.com/drugs/DB21531
    Experimental

    Zavolosotine is a small molecule drug. The usage of the INN stem '-sotine' in the name indicates that Zavolosotine is a non-peptidic somatostatin receptor agonist.

  4. Drug

    Branosotine

    go.drugbank.com/drugs/DB21674
    Experimental

    Branosotine is a small molecule drug. The usage of the INN stem '-sotine' in the name indicates that Branosotine is a non-peptidic somatostatin receptor agonist.

  5. Drug

    Nesvategrast

    go.drugbank.com/drugs/DB19337
    Investigational

    Nesvategrast is under investigation in clinical trial NCT05409235 (Nesvategrast (OTT166) in Diabetic Retinopathy (DR)).

  6. Drug

    N,N-dimethylarginine

    go.drugbank.com/drugs/DB01686
    Experimental

    Asymmetric dimethylarginine (ADMA) is a naturally occurring chemical found in blood plasma. … It is a metabolic by-product of continual protein modification processes in the cytoplasm of all human cells which is closely related to L-arginine, a conditionally-essential amino acid.

    Synonyms: guanidino-N,N-dimethylarginine, N(G),N(G)-Dimethylarginine
  7. Drug

    Ruserontinib

    go.drugbank.com/drugs/DB21555
    Investigational

    Ruserontinib is a small molecule drug. The usage of the INN stem '-tinib' in the name indicates that Ruserontinib is a tyrosine kinase inhibitor. … Ruserontinib is under investigation in clinical trial NCT04716114 (A Study of SKLB1028 Versus Salvage Chemotherapy in Patients With Relapsed or Refractory (R/R) AML With FLT3-Mutated).

  8. Drug

    Enbezotinib

    go.drugbank.com/drugs/DB21565
    Investigational

    Enbezotinib is a small molecule drug. The usage of the INN stem '-tinib' in the name indicates that Enbezotinib is a tyrosine kinase inhibitor. … Enbezotinib is under investigation in clinical trial NCT04161391 (Study of TPX-0046, A RET/SRC Inhibitor in Adult Subjects With Advanced Solid Tumors Harboring RET Fusions or Mutations).

  9. Drug

    Utatrectinib

    go.drugbank.com/drugs/DB21295
    Investigational

    Utatrectinib is a small molecule drug. The usage of the INN stem '-trectinib' in the name indicates that Utatrectinib is a tropomyosin receptor kinase (TRK) inhibitor. … Utatrectinib is under investigation in clinical trial NCT01468324 (AZD7451 for Recurrent Gliomas). Utatrectinib has a monoisotopic molecular weight of 382.17 Da.

  10. Drug

    Chlorophyll B

    go.drugbank.com/drugs/DB04506
    Experimental

    It is a component of both intra- and extracellular fluids and is excreted in the urine and feces. … Its salts are essential in nutrition, being required for the activity of many enzymes, especially those concerned with oxidative phosphorylation.